STAND NUMBER: 264
We want to create a world where people can live longer. A world where the best minds continue doing their best work. A world where we can spend more time with our loved ones.
Medopad's technology takes a modular approach which means we cover a wide variety of disease areas to deliver better and more personalised care by transforming the way patients and data interact with clinicians. Our Artificial Intelligence division uses data collected through our platform to generate predictive insights which will be able to detect life threatening medical conditions.
We partner closely with the world's largest healthcare systems, pharma companies, research institutes, insurers and technology companies like Apple and Tencent to solve some of the biggest problems in rare, chronic and complex disease monitoring.
Medopad was recently named a $1 billion health tech company in the making by KPMG.